Biotech Values

[Mpower]

Agree on all counts. I opined about this in post #103342 (http://investorshub.advfn.com/boards/read_msg.aspx?message_id=54014381)

If the FDA continues to hold off on TEVA's application through late October, i think buyers will start to recognize that its not a "bureaucratic" delay and that there are likely deeper issues with TEVA's mL application.

I suspect buyers will step in at that time, and we could start to see MNTA's PPS rise back to low-mid twenty levels. Thus, IMHO, this is an excellent buying opportunity.

That being said, I have been very mistaken in my prognostication with respect to MNTA PPS. That being said, at these levels, it may be an excellent take out target. It's so darn cheap....